|
---|
As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
---|
|
---|
3/28/24‡ IGC Pharma, Inc. 8-K:1,3,8,9 3/22/24 13:326K Federal Filings, LLC/FA
7/7/23‡ IGC Pharma, Inc. 8-K:1,3,9 6/30/23 13:364K Federal Filings, LLC/FA
5/13/20 IGC Pharma, Inc. 8-K:1,2,3,9 5/11/20 2:364K Federal Filings, LLC/FA
4/6/16 IGC Pharma, Inc. 8-K:2,3,9 3/31/16 2:35K Federal Filings, LLC/FA
3/30/16‡ IGC Pharma, Inc. 8-K:3,9 3/23/16 3:145K Federal Filings, LLC/FA
3/18/16 IGC Pharma, Inc. 8-K:3,9 3/16/16 3:131K Federal Filings, LLC/FA
3/1/16 IGC Pharma, Inc. 8-K:3,9 2/24/16 3:131K Federal Filings, LLC/FA
2/16/16 IGC Pharma, Inc. 8-K:1,2,3,9 2/11/16 3:215K Federal Filings, LLC/FA
12/23/14 IGC Pharma, Inc. 8-K:1,3,9 12/18/14 3:196K Federal Filings, LLC/FA
7/3/14 IGC Pharma, Inc. 8-K:3,8,9 6/27/14 2:36K Federal Filings, LLC/FA
6/5/14‡ IGC Pharma, Inc. 8-K:1,2,3,9 5/31/14 3:333K Federal Filings, LLC/FA
3/26/14 IGC Pharma, Inc. 8-K:1,2,3,9 3/21/14 2:51K Federal Filings, LLC/FA
10/12/12 India Globalization Capital, Inc. 8-K:1,2,3,9 10/9/12 3:162K Federal Filings, LLC/FA
1/6/12 India Globalization Capital, Inc. 8-K:2,3,9 12/30/11 2:42K Federal Filings, LLC/FA
3/25/11 India Globalization Capital, Inc. 8-K:1,2,3,9 3/24/11 3:185K Federal Filings, LLC/FA
2/25/11 India Globalization Capital, Inc. 8-K:1,2,3,9 2/25/11 3:158K Federal Filings, LLC/FA
10/21/09 India Globalization Capital, Inc. 8-K:1,2,3,910/16/09 4:490K Federal Filings, LLC/FA
10/8/09 India Globalization Capital, Inc. 8-K:1,2,3,9 10/5/09 3:288K Federal Filings, LLC/FA
10/6/08 India Globalization Capital, Inc. 8-K:1,2,3,9 9/30/08 4:408K Federal Filings, LLC/FA
1/16/08 India Globalization Capital, Inc. 8-K:1,2,3,9 1/8/08 3:151K Federal Filings, LLC/FA
____________ | ‡ | A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET. The legal “Filed As Of” date may be the next, or another, day. | ¹ | Filing/Form Type: | | 8-K | Current Report — Form 8-K { Item 1: Business & Operations; 2: Financial Info; 3: Securities & Trading; 4: Accountants & Accounting; 5: Governance & Management; 6: Asset-Backed Securities; 7: Disclosures; 8: Events; 9: Financials }. |
|